About Research Institute of South Florida, Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Research Institute of South Florida, Inc.
During the past decade, Research Institute of South Florida, Inc. conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 10 clinical trials were completed, i.e. on
average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 4 clinical trials were completed. i.e. 40%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Research Institute of South Florida, Inc." #1 sponsor was "Pfizer" with 3 trials, followed by "Ferring Pharmaceuticals" with 2 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Janssen Vaccines & Prevention B.V."
with 2 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Research Institute of South Florida, Inc."
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Research Institute of South Florida, Inc.
According to Clinical.Site data, the most researched conditions in "Research Institute of South Florida, Inc." are
"Asthma" (2 trials), "Cardiovascular Disease" (2 trials), "Chronic Idiopathic Constipation" (2 trials), "Influenza" (2 trials) and "Influenza, Human" (2 trials). Many other conditions were trialed in "Research Institute of South Florida, Inc." in a lesser frequency.
Clinical Trials Intervention Types at Research Institute of South Florida, Inc.
Most popular intervention types in "Research Institute of South Florida, Inc." are "Drug" (17 trials), "Biological" (4 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "Elobixibat 10 mg" (2 trials), "bococizumab (PF-04950615)" (2 trials), "1% SPL7013 Gel" (1 trials) and "Ad26.RSV.preF-based Vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Research Institute of South Florida, Inc.
The vast majority of trials in "Research Institute of South Florida, Inc." are
21 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Research Institute of South Florida, Inc.
Currently, there are NaN active trials in "Research Institute of South Florida, Inc.".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in Research Institute of South Florida, Inc.,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Research Institute of South Florida, Inc., 2 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".